Shane Maltbie
Financieel Directeur/CFO bij HILLEVAX, INC.
Vermogen: 1 M $ op 31-05-2024
Profiel
Shane Maltbie is currently the Chief Financial Officer at HilleVax, Inc. He previously worked as the Director-Technical Accounting at PAREXEL International Corp.
from 2013 to 2015.
From 2019 to 2021, he served as the Vice President-Finance at TScan Therapeutics, Inc. Additionally, he held the position of Chief Accounting Officer & VP-Corporate Finance at Axcella Health, Inc. in 2019.
Mr. Maltbie completed his undergraduate degree at Hartwick College and his graduate degree at Northeastern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
HILLEVAX, INC
0.18% | 08-02-2024 | 88 178 ( 0.18% ) | 1 M $ | 31-05-2024 |
Actieve functies van Shane Maltbie
| Bedrijven | Functie | Begin |
|---|---|---|
| HILLEVAX, INC. | Financieel Directeur/CFO | 06-01-2023 |
Eerdere bekende functies van Shane Maltbie
| Bedrijven | Functie | Einde |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01-12-2021 |
| AXCA HEALPAR | Comptroller/Controller/Auditor | 29-11-2019 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01-10-2015 |
Opleiding van Shane Maltbie
| Hartwick College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AXCA HEALPAR | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| HILLEVAX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
